Please wait...
GulfBase Live Support
- TAQA Group reports Q1 revenue of $ 3.87bn, up 3.8%
- Bahrain All Share Index closes higher
- UAE airline Etihad places major aircraft order with Boeing
- UN forecasts global economic growth to drop to 2.4% in 2025
- Dubai gold rate shoots up after Dh10 plus drop - in hours
- Abraj Energy signs deal with BP for drilling rig in Block 61
- Commercial Bank launches new CB Corporate Banking App
- QSE sees 62% of stocks in the red; index loses 19 points
- Financial markets development essential to Qatar's comprehensive financial strategy: QCB Governor
- Emirates NBD pilots new AI compliance tech to reduce risks, improve payment speed
- :17
- :16.5
- ('000):3,213
- ( '000):53,336
- :0
-
17,813 - :0
- :
- 63.11%
- 2.47%
-
103 -
():
296,341.42 - ():517,733
- :0.57
- Performance Comparison
- :Nomu - Parallel Market
- :Health Care Equipment & Svc
- :Micro Cap
- :Health Care
Company Overview
- :27/09/2016
- :SAR 32,125,000
- :SAR 10
Activities
Jana Medical Co. is a leading company in the healthcare sector based in Saudi Arabia. Founded in 2016, the company specializes in the manufacture and supply of medical devices and equipment. Jana Medical operates as a holding company, with subsidiaries that focus on various medical fields, including anesthesia, neurosurgery, spine, ear, nose, and throat (ENT) surgeries.
The company is headquartered in the Al-Nafl District of Riyadh and has established itself as a key player in the Kingdom's healthcare industry. Jana Medical Co. is committed to providing high-quality medical devices that meet the needs of healthcare professionals and patients alike.
Jana Medical Co.'s product range includes advanced medical devices for various surgical procedures, ensuring that healthcare providers have access to the latest technology and equipment. The company's dedication to innovation and quality has earned it a strong reputation in the industry.
In November 2024, Jana Medical Co. made its debut on the Saudi Arabian Stock Exchange (Tadawul) under the ticker symbol 9616. This listing marks a significant milestone for the company, reflecting its growth and potential in the market.
-
Chairman:Eid S. A. Al-Otaibi
-
Vice-chairman:Hani K. K. Nijm
-
CEO:Wissam S. Ghazzaoui
-
General Manager:
-
Managing Director:
-
Board Members:
Abdullah N. B. Al-Badr
Fahd M. M. Al-Ali
Jamal M. W. Al-Otaibi
Jameel M. W. Al-Otaibi
Mushari T. M. Al-Motairi
-
Auditors:
RSM United Accountants for Professional Consulting
Chief Financial Officer (CFO)
| Announced On | Period | As Of | Net Profit (SAR Mil) | Growth (%) |
|---|---|---|---|---|
| 27/03/2025 | 12-Month | 31/12/2024 | -23 | 0 |
- ahmed.awad@janamd.com
- www.janamd.com.sa
- Riyadh 13312
| Market Cap US$ Mil |
Last Price Local Cry |
Price Change (%) 1 Day |
Price Change (%) 1 Year |
P/E TTM | P/B MRQ | Dividend Yield (%) | Beta | ROA (%) | ROE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| SULAIMANALHABIB | 25,184.25 | 268 | -0.75 | -2.58 | 42.44 | 0 | 0 | 0 | 0 | 0 |
| PUREHEALTH | 8,196.24 | 2.7 | -0.37 | 0 | 26.81 | 0 | 0 | 0 | 0 | 0 |
| ARMAH | 7,881.26 | 89.8 | -0.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NAHDI | 4,219.76 | 122.2 | 0.32 | -15.6 | 19 | 0 | 0 | 0 | 0 | 0 |
| MOUWASAT | 4,136.08 | 76.7 | -1.16 | -28.46 | 23.58 | 2.79 | 0 | 0.81 | 13.85 | 22.49 |
| JAMJOOMPHARMA | 3,357.9 | 180 | 0 | 18.09 | 36.06 | 0 | 0 | 0 | 0 | 0 |
| DALLAHHEALTH | 3,087.39 | 117 | -1.35 | -5.63 | 24.6 | 4.31 | 0 | 0.93 | 12.1 | 17.53 |
| FAKEEHCARE | 2,865.73 | 46.5 | 0.32 | 0 | 39.94 | 0 | 0 | 0 | 0 | 0 |
| AME | 2,141.59 | 115.8 | 0.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CARE | 1,941.09 | 166.2 | 2.33 | -16.19 | 26.54 | 7.55 | 0 | 0.85 | -0.59 | -0.89 |
| NABAALSAHA | 1,922.4 | 67.2 | -2.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TIBBIYAH | 1,700.27 | 31.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SAUDIGERMANHEALTH | 1,569.83 | 63.3 | -1.1 | -28.25 | 27.87 | 3.61 | 0 | 0.79 | 11.92 | 18.76 |
| PROMEDEX | 892.64 | 95.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SPIMACO | 863.46 | 26.9 | -0.38 | -2.21 | 80.02 | 1.23 | 0 | 0.91 | 8.47 | 15.11 |
| ALMUJTAMAMEDICAL | 784.84 | 32 | 3.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AVALONPHARMA | 688.64 | 126.8 | -1.86 | 0 | 32.12 | 0 | 0 | 0 | 0 | 0 |
| MIRAL | 621.48 | 116.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MIDAN | 524.21 | 789 | 0 | -4.78 | 14.01 | 1.38 | 0 | 0 | 12.06 | 17.87 |
| QOMEL | 508.35 | 55 | 0.91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JULPHAR | 446.52 | 1.38 | -2.82 | 0 | -71.36 | 0.69 | 5.27 | 0.2 | 4.09 | 0 |
| AYYAN | 401.76 | 14.7 | -1.87 | -8.1 | -7.15 | 1.5 | 0 | 0.81 | -2 | -2.64 |
| GMPC | 393.81 | 2.14 | 3.38 | 0 | 0 | 1.1 | 3 | -0.08 | 75.81 | 111.42 |
| ATC.KW | 364.68 | 741 | 0 | 0 | 157.88 | 2.25 | 1.82 | -0.01 | 2.93 | 12.88 |
| MCGS | 346.4 | 4.64 | 2.65 | -0.04 | 21.18 | 0.13 | 5.86 | 0.98 | 6.76 | 7.99 |
| EQUIPMENTHOUSE | 324.2 | 39.9 | -1.61 | 5.1 | 25.3 | 0 | 0 | 0 | 0 | 0 |
| LANA | 287.82 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TMC | 229.4 | 22 | 2.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RPM | 223.75 | 4.21 | 2.43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BURJEEL | 209.69 | 1.46 | -1.36 | 0 | 1.65 | 0 | 0 | 0 | 0 | 0 |
| CMCER | 143.64 | 6.93 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALMODAWAT | 113.8 | 18.12 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FUTURECARE | 50.77 | 3.73 | -2.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QGMD | 43.09 | 1.37 | 0 | 16.69 | -2.31 | 0.23 | 0 | 0.76 | -6.18 | 0 |
| SMILECARE | 30.65 | 5.72 | -0.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BALSMMEDICAL | 25.65 | 77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALRAZI | 17.09 | 42.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JANA | 14.49 | 16.6 | -1.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Information Co.
P.O. Box 69410, Jeddah 11547, Saudi Arabia